Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma

Zhang, DD; Liang, JP; Lv, YH; Huang, XK; Guo, WH

Guo, WH (通讯作者)，Zhongshan City Peoples Hosp, Dept Resp & Crit Care Med, Zhongshan, Guangdong, Peoples R China.

MEDICINE, 2022; 101 (52):

Abstract

Rationale:Malignant pleural mesothelioma (MPM) is a malevolent tumor originated from pleura and often leads to poor prognosis. Chemotherapy of pemetre......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索